For some people, anxiety fades once the trigger passes. For others, it lingers no matter how good their sleep or diet has been lately, and part of that difference comes down to how the brain is wired to let go of fear. Research on a common variant in the BDNF gene has found that it measurably disrupts the brain circuitry responsible for fear extinction, the process of learning that a once-threatening situation is now safe. When that circuitry doesn’t work efficiently, anxiety isn’t being poorly managed. It’s not being unlearned the way it normally would.
Contents
How the BDNF Gene Affects Whether Fear Responses Actually Fade
BDNF stands for brain-derived neurotrophic factor, a protein that helps neurons form and strengthen connections. A common variant of this gene, known as Val66Met, reduces how much BDNF gets released during neural activity, particularly in circuits connecting the hippocampus and prefrontal cortex.
Multiple human and animal studies have found that carriers of this variant show impaired fear extinction learning, meaning the natural process of a fear response weakening once a threat is confirmed to be gone works less efficiently. Researchers have traced part of this effect to how the variant disrupts the health of connections on neurons in circuits meant to send a calming, safety-confirming signal back to the amygdala. In practical terms, someone with this variant may have a well-managed lifestyle and still find that a specific worry simply doesn’t fade the way it does for someone else, because the biological “all clear” signal isn’t being sent as strongly.
Why the NPY Gene Determines How Much Natural Anti-Anxiety Signal Is on Tap
A separate system involves a small brain chemical called neuropeptide Y, or NPY, which acts as one of the body’s own natural anti-anxiety signals, largely by calming activity in the amygdala.
What Low NPY Signaling Looks Like
The amount of NPY available is influenced by variation in the NPY gene itself. A review of NPY research in relation to anxiety and stress disorders describes a promoter variant associated with meaningfully lower NPY expression, which in turn has been linked to higher amygdala reactivity and greater trait anxiety. Since NPY’s whole job is to counterbalance the brain’s threat-response chemistry, having less available means there’s less natural braking power on anxious arousal once it kicks in.
Why This Compounds Over Time
People with lower baseline NPY signaling don’t just react more strongly in the moment. Research in stress-resilience models suggests they also recover more slowly afterward, since the same signal that dampens the initial reaction is also involved in returning the system to baseline.
The Role of TMEM132D in Panic-Prone Brain Wiring
A third gene, less well known but heavily replicated, is TMEM132D. Unlike the classic neurotransmitter genes involved in anxiety, TMEM132D is thought to be involved in how neurons connect and communicate structurally.
A large multi-site replication study confirmed an earlier genome-wide finding linking specific TMEM132D variants to panic disorder, with the strongest association found in people without other major psychiatric conditions complicating the picture. Related research has linked these same variants to greater anxiety symptom severity and larger amygdala volume. This gene doesn’t fit neatly into the “too much stress chemical” or “not enough calming chemical” framework. It’s a reminder that some genetic contributions to chronic anxiety work through the physical wiring of fear circuits themselves, not just the chemical messengers running through them.
Genetics Explains the Resistance, Not the Inevitability
None of this means chronic anxiety is untreatable or fixed. Therapy approaches built specifically around fear extinction, like exposure-based treatment, can still work even for people with a less efficient BDNF variant, and exercise has been shown in some research to help restore fear extinction learning in exactly this group. What genetics does explain is why diet and sleep improvements alone sometimes aren’t enough. These lifestyle changes support brain health broadly, but they don’t necessarily correct a specific bottleneck in fear-processing circuitry.
If your anxiety has stuck around despite doing the “right” things for your general health, it may be worth understanding whether your own GABA, glutamate, and related fear-circuitry genetics are part of the picture. A report covering the GABA and glutamate pathway can map where your own variants fall.
Frequently Asked Questions
Why doesn’t my anxiety improve even with good sleep and diet?
Genetic variants like BDNF Val66Met can impair fear extinction learning, the brain process that normally lets fear responses fade once a threat is confirmed gone. Sleep and diet support general brain health but don’t necessarily correct this specific circuitry issue.
What does the NPY gene have to do with anxiety?
NPY produces a natural anti-anxiety signal that helps calm the amygdala. Certain genetic variants are linked to lower NPY expression, which research has associated with higher amygdala reactivity and greater trait anxiety.
Is TMEM132D a well-established anxiety gene?
Yes, relative to many candidate genes in psychiatric genetics. TMEM132D variants have been replicated across multiple independent studies as associated with panic disorder and anxiety symptom severity, distinguishing it from many anxiety-related genes that haven’t held up under replication.
